RYOIX Mutual Fund
RYOIX Mutual Fund
RYOIX Mutual Fund
Rydex Biotechnology Fund Investor Class
RYOIX Mutual Fund Overview
RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $103.9M in net assets. RYOIX expense ratio is 1.38%, holding 75 positions across sectors including Health Care. Inception date: 1998-04-01.
RYOIX performance shows a YTD return of 15.20%. The 1-year return is 47.43% and the 5-year return is 5.72%. RYOIX dividend yield stands at 10.87%, paid annually.
RYOIX top holdings include Abbvie Inc. (7.4%), Amgen Inc. (5.2%), Gilead Sciences (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). Go to all RYOIX holdings, RYOIX sectors, or RYOIX dividends.
RYOIX can be compared against other funds. Use RYOIX overlap to find shared positions, or RYOIX vs another fund for a side-by-side view. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.